RETHINKING Multiple Sclerosis in times of COVID-19
During the first edition of the Brain Innovation Days, participants had the opportunity to explore the “Living with MS in times of COVID-19: A case for rethinking MS care in the EU” poster exhibition, featuring portraits and quotes of people living with multiple sclerosis (MS), patient advocates and policy makers.
The COVID-19 pandemic affected us all, but it did not affect us all equally. People living with chronic conditions, such as Multiple Sclerosis (MS), have faced uncertainty and disruptions in their care pathways, and as a consequence, have dealt and will continue to deal with the long-term physical and emotional implications of not receiving optimal care.
The objective of “RETHINKING MS in times of COVID-19” is to provide concrete and tangible testimonies from relevant stakeholders – clinicians, MS patients, patient advocates, pharma representatives – impacted by the disruption in care, which proved both an obstacle and an accelerator for the implementation of good practices.